The Cartagena Protocol is not applicable to this product. While the manufacuturing process is proprietary, current methods of extraction and purification would eliminate the presence of any whole, vialble organisms. This is not a sterile product. Prepared solutions may be filter-sterilized prior to use.
P4912
Phospholipase D from Streptomyces sp.
Type VII, lyophilized powder, ≥150 units/mg solid
Synonym(s):
Lecithinase D, Phosphatidylcholine phosphatidohydrolase
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Size/SKU | Availability | Price |
|---|
About This Item
CAS Number:
UNSPSC Code:
12352204
NACRES:
NA.54
EC Number:
232-639-8
MDL number:
Specific activity:
≥150 units/mg solid
Biological source:
Streptomyces sp.
Pricing and availability is not currently available.
biological source
Streptomyces sp.
Quality Segment
type
Type VII
form
lyophilized powder
specific activity
≥150 units/mg solid
storage temp.
−20°C
Application
Phospholipase D (PLD) has been used to hydrolyze the phosphate bonds of phospholipids and sphingomyelin to yield the corresponding phosphatidic acid. It has also been used to study metabolic labeling and direct imaging of choline phospholipids in vivo by measuring propargyl-Cho incorporation. Furthermore, PLD has been used in purification and kinetic studies.
Biochem/physiol Actions
Phospholipase D is glycerophospholipid-specific. It is markedly less active on sphingomyelins and lysophospholipids. Phospholipase D hydrolyzes the phosphate bonds of phospholipids and sphingomyelin to give the corresponding phosphatidic acid.
Hydrolyzes the phosphate bonds of phospholipids and sphingomyelin to give the corresponding phosphatidic acid.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Analysis Note
Protein by biuret
Other Notes
One unit will liberate 1.0 μmole of choline from 1,2-Dioleoyl-sn-glycero-3-phosphocholine per hour at pH 8.0 at 37 °C.
1 of 1
This Item | |||
|---|---|---|---|
| biological source Streptomyces sp. | biological source - | biological source - | biological source - |
| specific activity ≥150 units/mg solid | specific activity 100-250 units/mg protein | specific activity 10-25 units/mg solid | specific activity ≥100 units/mg solid |
| form lyophilized powder | form lyophilized powder | form lyophilized powder | form lyophilized powder |
| storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −20°C |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| type Type VII | type - | type - | type Type IV |
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
Storage Class
11 - Combustible Solids
wgk
WGK 3
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
-
本製品はカルタヘナ法に該当する試薬でしょうか。また菌体除去のためのフィルターろ過はされているのでしょうか。
1 answer-
Helpful?
-